Literature DB >> 31829804

Skeletal muscle transcriptional networks linked to type I myofiber grouping in Parkinson's disease.

Kaleen M Lavin1,2, Stuart C Sealfon3,4, Merry-Lynn N McDonald5,6,7, Brandon M Roberts1,2, Katarzyna Wilk3,4, Venugopalan D Nair3,4, Yongchao Ge3,4, Preeti Lakshman Kumar5,6,7, Samuel T Windham8,2, Marcas M Bamman1,6,9,2,10.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder impacting cognition, movement, and quality of life in >10 million individuals worldwide. We recently characterized and quantified a skeletal muscle pathology in PD represented by exaggerated type I myofiber grouping presumed to result from denervation-reinnervation processes. Our previous findings indicated that impaired neuromuscular junction integrity may be involved in type I grouping, which is associated with excessive motor unit activation during weight-bearing tasks. In this study, we performed transcriptional profiling to test the hypothesis that type I grouping severity would link to distinct gene expression networks. We generated transcriptome-wide poly(A) RNA-Seq data from skeletal muscle of individuals with PD [n = 12 (9 men, 3 women); 67 ± 2 yr], age- and sex-matched older adults (n = 12; 68 ± 2 yr), and sex-matched young adults (n = 12; 30 ± 1 yr). Differentially expressed genes were evaluated across cohorts. Weighted gene correlation network analysis (WGCNA) was performed to identify gene networks most correlated with indicators of abnormal type I grouping. Among coexpression networks mapping to phenotypes pathologically increased in PD muscle, one network was highly significantly correlated to type I myofiber group size and another to percentage of type I myofibers found in groups. Annotation of coexpressed networks revealed that type I grouping is associated with altered expression of genes involved in neural development, postsynaptic signaling, cell cycle regulation and cell survival, protein and energy metabolism, inflammation/immunity, and posttranscriptional regulation (microRNAs). These transcriptomic findings suggest that skeletal muscle may play an active role in signaling to promote myofiber survival, reinnervation, and remodeling, perhaps to an extreme in PD.NEW & NOTEWORTHY Despite our awareness of the impact of Parkinson's disease (PD) on motor function for over two centuries, limited attention has focused on skeletal muscle. We previously identified type I myofiber grouping, a novel indicator of muscle dysfunction in PD, presumably a result of heightened rates of denervation/reinnervation. Using transcriptional profiling to identify networks associated with this phenotype, we provide insight into potential mechanistic roles of skeletal muscle in signaling to promote its survival in PD.

Entities:  

Keywords:  Parkinson’s disease; RNA-Seq; muscle histology; neuromuscular junction; type I grouping; weighted gene correlation network analysis

Mesh:

Year:  2019        PMID: 31829804      PMCID: PMC7052589          DOI: 10.1152/japplphysiol.00702.2019

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  86 in total

1.  DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.

Authors:  James F Burrows; Michael J McGrattan; Anne Rascle; Martine Humbert; Kwang-Hyun Baek; James A Johnston
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

2.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

3.  Histochemical aspects of five limb muscles in old age. An autopsy study.

Authors:  F G Jennekens; B E Tomlinson; J N Walton
Journal:  J Neurol Sci       Date:  1971-11       Impact factor: 3.181

4.  Glycine receptor α3 and α2 subunits mediate tonic and exogenous agonist-induced currents in forebrain.

Authors:  Lindsay M McCracken; Daniel C Lowes; Michael C Salling; Cyndel Carreau-Vollmer; Naomi N Odean; Yuri A Blednov; Heinrich Betz; R Adron Harris; Neil L Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

5.  Motor unit changes in sporadic idiopathic Parkinson's disease.

Authors:  J N Caviness; B E Smith; J C Stevens; C H Adler; R J Caselli; C A Reiners; J G Hentz; M D Muenter
Journal:  Mov Disord       Date:  2000-03       Impact factor: 10.338

6.  The occurrence of fibre-type grouping in healthy human muscle: a quantitative study of cross-sections of whole vastus lateralis from men between 15 and 83 years.

Authors:  J Lexell; D Y Downham
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 7.  Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins.

Authors:  Steffen Halbgebauer; Patrick Öckl; Katharina Wirth; Petra Steinacker; Markus Otto
Journal:  Mov Disord       Date:  2016-05-02       Impact factor: 10.338

8.  Age-related neuromuscular changes affecting human vastus lateralis.

Authors:  M Piasecki; A Ireland; D Stashuk; A Hamilton-Wright; D A Jones; J S McPhee
Journal:  J Physiol       Date:  2015-12-15       Impact factor: 5.182

Review 9.  Ubiquitin and Parkinson's disease through the looking glass of genetics.

Authors:  Helen Walden; Miratul M K Muqit
Journal:  Biochem J       Date:  2017-04-13       Impact factor: 3.857

10.  Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection.

Authors:  Y Koutmani; P K Politis; M Elkouris; G Agrogiannis; M Kemerli; E Patsouris; E Remboutsika; K P Karalis
Journal:  Mol Psychiatry       Date:  2013-02-05       Impact factor: 15.992

View more
  6 in total

1.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

2.  Comparison of erector spinae fatigability between female patients with Parkinson's disease and healthy individuals: a cross sectional pilot study.

Authors:  Yukihide Nishimura; Hiroyuki Tsuboi; Ken-Ya Murata; Yuta Minoshima; Hideyuki Sato; Yuichi Umezu; Fumihiro Tajima
Journal:  BMC Neurol       Date:  2022-05-23       Impact factor: 2.903

3.  Muscle transcriptional networks linked to resistance exercise training hypertrophic response heterogeneity.

Authors:  Kaleen M Lavin; Margaret B Bell; Jeremy S McAdam; Bailey D Peck; R Grace Walton; Samuel T Windham; S Craig Tuggle; Douglas E Long; Philip A Kern; Charlotte A Peterson; Marcas M Bamman
Journal:  Physiol Genomics       Date:  2021-04-19       Impact factor: 3.107

4.  Rehabilitative Impact of Exercise Training on Human Skeletal Muscle Transcriptional Programs in Parkinson's Disease.

Authors:  Kaleen M Lavin; Yongchao Ge; Stuart C Sealfon; Venugopalan D Nair; Katarzyna Wilk; Jeremy S McAdam; Samuel T Windham; Preeti Lakshman Kumar; Merry-Lynn N McDonald; Marcas M Bamman
Journal:  Front Physiol       Date:  2020-06-17       Impact factor: 4.566

5.  Effect of Parkinson's Disease on Cardio-postural Coupling During Orthostatic Challenge.

Authors:  Rabie Fadil; Asenath X A Huether; Ajay K Verma; Robert Brunnemer; Andrew P Blaber; Jau-Shin Lou; Kouhyar Tavakolian
Journal:  Front Physiol       Date:  2022-06-03       Impact factor: 4.755

6.  Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.

Authors:  Shulei He; Lu Huang; Ci Shao; Tiejian Nie; Li Xia; Bozhou Cui; Fangfang Lu; Lin Zhu; Bolin Chen; Qian Yang
Journal:  Transl Neurodegener       Date:  2021-07-28       Impact factor: 8.014

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.